美國BioCryst Pharmaceuticals
BioCryst公司是一家在治療傳染性疾病、癌癥及炎癥的小分子藥物研發領域處于世界領先地位的醫藥公司。Peramivir是BioCryst公司研發的可有效阻止流感病毒神經氨酸酶交互作用的抗病毒體,而流感病毒神經氨酸酶是促使流感病毒在寄主體內傳播的一種關鍵酶。在實驗中,peramivir對H1N1甲流原病毒株顯示出活性,同時對并發及非并發癥流感有顯著效果。
Founded in 1986, BioCryst has over 80 employees spread across our two locations in Birmingham, Alabama and Durham, North Carolina. With expertise in drug discovery, clinical development and regulatory affairs, we continue to advance our compounds, peramivir, forodesine and BCX4208, and to generate new compounds from our own discovery engine—structure-based drug design.
We are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives.
The commitment of BioCryst has remained unchanged. We continue to be passionate about advancing novel therapeutics for patients with serious diseases.